Amazon may regenerate the medication supply chain and exude transparency to the health-care method, but it has to be cautious with patient information, panelists said at CNBC’s “Healthy Returns” summit.
It’s no more a matter about if Amazon is getting into healthcare, but the technology giant has stayed mum about what exactly it is doing. Only the thought of how Amazon entering the distance has resulted in the business to react, ” said Truveris CEO Faisal Mushtaq.
Read more on cnbc